Skip to main content

Table 3 Predictors of CRNA in Canada

From: Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact

Predictor

No. of articles reporting significance

Citations

Higher out-of-pocket costsa

13

[2, 3, 37, 39,40,41, 47, 50,51,52,53, 55, 56]

Lower income or low financial flexibility

9

[3, 38,39,40, 43, 46, 48, 54, 55]

Lack of drug insurance

7

[40, 41, 43, 46, 47, 54, 55]

Younger age

6

[38,39,40, 43, 46, 47]

Poor self-reported health status

5

[39, 40, 43, 46, 47]

Province of residence (e.g., Ontario instead of Quebec, or British Columbia instead of Ontario or Quebec)

4

[38, 43, 46, 47]

Several chronic health conditions

2

[38, 46]

High cost of drugs

2

[35, 54]

Low/medium drug importance from individual’s perspective

2

[54, 55]

Not feeling involved in treatment decisions

2

[39, 55]

First Nations status

1

[39]

  1. aIncludes studies comparing the rates of CRNA pre- and post-copayment policy